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ABSTRACT 22 
 23 
Viruses are major evolutionary drivers of insect immune systems. Much of our 24 
knowledge of insect immune responses derives from experimental infections 25 
using the fruit fly Drosophila melanogaster. Most experiments, however, employ 26 
lethal pathogen doses through septic injury, frequently overwhelming host 27 
physiology. While this approach has revealed several immune mechanisms, it is 28 
less informative about the fitness costs hosts may experience during infection in 29 
the wild. Using both systemic and oral infection routes we find that even 30 
apparently benign, sub-lethal infections with the horizontally transmitted 31 
Drosophila C Virus (DCV) can cause significant physiological and behavioral 32 
morbidity that is relevant for host fitness. We describe DCV-induced effects on 33 
fly reproductive output, digestive health, and locomotor activity, and we find that 34 
viral morbidity varies according to the concentration of pathogen inoculum, host 35 
genetic background and sex. Notably, sub-lethal DCV infection resulted in a 36 
significant increase in fly reproduction, but this effect depended on host 37 
genotype. We discuss the relevance of sub-lethal morbidity for Drosophila 38 
ecology and evolution, and more broadly, we remark on the implications of 39 
deleterious and beneficial infections for the evolution of insect immunity.  40 
 41 
 42 
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INTRODUCTION 47 
Viral infections are pervasive throughout the living world (Suttle, 2005; Rosario 48 
& Breitbart, 2011). Viruses of insects have attracted considerable interest (Miller 49 
& Ball, eds, 1998), in part due to their potential role in the bio-control of insect 50 
pests (Lacey et al., 2015), and also because insects are vectors of many viral 51 
pathogens of plants (Whitfield et al., 2015), animals and humans (Conway et al., 52 
2014). The abundance and diversity of insect viruses, combined with the 53 
extensive morbidity and mortality they cause, make viral infections potentially 54 
powerful determinants of insect population dynamics and evolution (Dwyer et 55 
al., 2004; Obbard et al., 2006; Wilfert et al., 2016).  56 
 57 
Much of our knowledge of insect immune responses to viral infections has come 58 
from work using the fruit fly Drosophila melanogaster, where the focus has been 59 
on elucidating the genetics underlying antiviral immunity (Dostert et al., 2005; 60 
Huszar & Imler, 2008; Kemp & Imler, 2009; Sabin et al., 2010; Magwire et al., 61 
2012). Several RNA viruses have been described and investigated in this context, 62 
including Nora virus (Habayeb et al., 2009), Drosophila A virus (DAV)(Ambrose 63 
et al., 2009), Flock House Virus (FHV) (Scotti et al., 1983) and Drosophila C Virus 64 
(DCV) (Jousset et al., 1977), a horizontally transmitted ssRNA virus in the 65 
Dicistroviridae family (Huszar & Imler, 2008). Initial investigations of DCV 66 
infection found that it replicates in the fly’s reproductive and digestive tissues 67 
(Lautié-Harivel & Thomas-Orillard, 1990) and that infection results in 68 
accelerated larval development but also causes mortality (Thomas-Orillard, 69 
1984; Gomariz-Zilber et al., 1995). More recent work has shown that systemic 70 
infection with elevated concentrations of DCV causes pathology within the fly’s 71 
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food storage organ, the crop, leading to intestinal obstruction, lower metabolic 72 
rate and reduced locomotor activity (Arnold et al., 2013; Chtarbanova et al., 73 
2014). There is also considerable genetic variation in fly survival when 74 
challenged systemically with DCV, which appears to be controlled by few genes 75 
of large effect (Magwire et al., 2012).  76 
 77 
While this level of detail concerning the physiological consequences and the 78 
underlying genetics of infection is remarkable, it is important to recognize that 79 
our knowledge of viral infections comes almost entirely from experimental 80 
infections that challenge model systems, such as Drosophila, with artificially high 81 
viral concentrations during systemic infections. Even in cases where natural 82 
routes of infection have been investigated (Gomariz-Zilber et al., 1995; Ferreira 83 
et al., 2014; Stevanovic & Johnson, 2015; Vale & Jardine, 2015), these have often 84 
been achieved by using much higher doses than flies are likely to encounter in 85 
the wild in order to cause significant mortality. Highly lethal systemic or oral 86 
infections have been useful in unravelling broad antiviral immune mechanisms 87 
(Dostert et al., 2005; Wang et al., 2006; Kemp & Imler, 2009; Nayak et al., 2013; 88 
Karlikow et al., 2014), but it is unlikely that the morbidity and mortality they 89 
cause is an accurate reflection of the level of disease experienced by flies in the 90 
wild, where viral infections appear to be widespread among many species of 91 
Drosophila as low level persistent infections with apparently little pathology 92 
(Kapun et al., 2010; Webster et al., 2015). Our understanding of the fitness costs 93 
of viral infection in Drosophila is therefore severely limited, which is striking 94 
given the evidence from population genetic data that viruses are major drivers of 95 
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adaptive evolution in Drosophila immune genes  (Obbard et al., 2006, 2009; Early 96 
et al., 2016). 97 
 98 
To gain a better understanding of the potential fitness costs of DCV infection, we 99 
measured the physiological and behavioural responses of flies challenged with 100 
DCV. We carried out two separate experiments, either challenging flies with a 101 
range of sub-lethal viral concentrations systemically through intra-thoracic 102 
injury (experiment 1) or exposing flies through the oral route of infection to a 103 
low, sub-lethal concentration of DCV (experiment 2). Our aim was not to 104 
compare the two routes of infection, but to address sub-lethal infections using 105 
both infection routes, as these are commonly employed in experimental 106 
infections. We focused on traits that have been previously shown to be affected 107 
by DCV infection such as survival, fecal excretion, and locomotor activity, as well 108 
as female reproductive output, which is ultimately important for evolutionary 109 
fitness. We find that even apparently benign, sub-lethal infections can cause 110 
significant physiological and behavioural morbidity that is relevant to fly fitness, 111 
and that these effects vary according to viral concentration, host genetic 112 
background and sex. 113 
 114 
  115 
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MATERIAL AND METHODS  116 
Fly lines and rearing conditions 117 
In experiment 1 (systemic DCV infection) we used Drosophila melanogaster line 118 
G9a+/+ described previously (Merkling et al., 2015), kindly provided by R. van Rij 119 
(Radboud University, Nijmegen, NL). This line was maintained on standard Lewis 120 
Cornmeal medium (Lewis, 2014) under standard laboratory conditions at 25°C, 121 
12h: 12h Light:Dark cycle. Experimental flies were generated by setting up 20 122 
replicate Lewis vials with 15 males and 15 females to mate and lay eggs for 24 123 
hours. Three-to-four-day-old adults that eclosed from the eggs laid during this 124 
period were infected systemically (see below) and then followed individually for 125 
health measures.  126 
 127 
In experiment 2 (oral DCV exposure) we used ten D. melanogaster lines from the 128 
Drosophila Genetic Reference Panel (DGRP): RAL-83, RAL-91, RAL-158, RAL-129 
237, RAL-287, RAL-317, RAL-358, RAL-491, RAL-732, and RAL-821. Given we 130 
had no prior knowledge of how the DGRP panel vary in response to oral DCV 131 
infection, these lines were chosen randomly. All lines were previously cleared of 132 
Wolbachia and have been maintained Wolbachia-free for at least 3 years. Fly 133 
stocks were kept at a density of 30 individuals in bottles on standard Lewis 134 
medium at 24.5± 0.5°C. Flies were allowed to mate and lay eggs for three days 135 
and then removed. When eggs had developed into three-day old imagoes, we 136 
picked 16 male and 16 female flies at random from each DGRP line (320 flies in 137 
total). Half of these flies (n=8 replicates) were individually exposed to DCV 138 
through the oral route of infection (see details below) and the other half were 139 
exposed to a sterile Ringers solution (7.2 g/L NaCl; 0.17 g/L CaCl2; 0.37 g/L KCl, 140 
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diluted in sterile water, pH 7.4) as a control (n=8 replicates). Following infection, 141 
all flies were kept individually in vials kept in incubators at 24.5°C ± 0.5 with a 142 
12h:12h light:dark cycle for the remainder of the experiment. Vials were 143 
randomized within trays to reduce any positional effects within incubators.  144 
 145 
DCV stock and culturing 146 
The Drosophila C Virus (DCV) isolate used in both experiments was originally 147 
isolated in Charolles, France (Jousset et al., 1977), and was produced in 148 
Drosophila line 2 (DL2) cells as described previously (Longdon et al., 2013; Vale 149 
& Jardine, 2015). Infectivity of the virus was calculated by measuring cytopathic 150 
effects in DL2 cells using the Reed-Muench end-point method to calculate the 151 
Tissue Culture Infective Dose 50 (TCID50) (Reed & Muench, 1938). The DCV stock 152 
used in this experiment had an infectivity of approximately 4x109 DCV infectious 153 
units (IU)/mL. This stock culture was serially diluted to achieve the desired 154 
concentrations (approximately 102 103 and 105 DCV IU/mL for systemic infection 155 
and 105 DCV IU/mL for oral infection) and kept at -80°C until needed.  156 
 157 
Systemic DCV infection and viral titers 158 
We exposed 20 individual male and female flies to each of 4 viral concentrations 159 
(160 flies in total)– 0 (control), 102, 103 and 105 DCV IU/ml, obtained by serial 160 
diluting the viral stock with 10mM Tris-HCl (pH 7.3). Flies were infected 161 
systemically by intra-thoracic pricking with a needle immersed in DCV 162 
suspension under light CO2 anesthesia. Control flies were pricked with a needle 163 
dipped in sterile10mM Tris-HCl (pH 7.3). An additional five individuals for each 164 
sex/dose combination were infected as described above to quantify DCV within 165 
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flies following infection, using the expression of DCV RNA. Flies were individually 166 
placed in TRI reagent (Ambion) following five days of infection (5 DPI), 167 
homogenized total RNA was extracted using Direct-zol RNA miniprep kit, which 168 
includes a DNAse step (Zymo Research), reverse-transcribed with M-MLV 169 
reverse transcriptase (Promega) and random hexamer primers, and then diluted 170 
1:2 with nuclease-free water. qRT-PCR was performed on an Applied Biosystems 171 
StepOnePlus system using Fast SYBR Green Master Mix (Applied Biosystems) 172 
and DCV primers, which include 5’-AT rich flaps to improve RT-PCR fluorescent 173 
signal (Afonina et al., 2007) (DCV_Forward:  5’ 174 
AATAAATCATAAGCCACTGTGATTGATACAACAGAC 3’;  DCV_Reverse: 175 
AATAAATCATAAGAAGCACGATACTTCTTCCAAACC). We measured the relative 176 
fold change in DCV RNA relative to rp49, (Dmel_rp49 Forward: 5’ 177 
ATGCTAAGCTGTCGCACAAATG 3’ ; Dmel_rp49 Reverse: 5’ 178 
GTTCGATCCGTAACCGATGT 179 
3’).  an internal Drosophila control gene, calculated as 2-Ct (Livak & Schmittgen, 180 
2001). 181 
 182 
Oral DCV exposure 183 
In separate pilot infections, we determined that a DCV culture diluted to contain 184 
approximately 105 DCV RNA copies was enough to establish a viable infection 185 
(Figure S1), but did not cause noticeable mortality, and we used this dilution of 186 
DCV stock to inoculate all ten DGRP lines. Individual flies were exposed to DCV in 187 
vials containing Agar (5% sugar) using 3mL plastic atomizer spray bottles 188 
containing 2mL of the sub-lethal DCV dilution. One spray, releasing roughly 50μL 189 
of DCV dilution (or sterile Ringer’s solution), was deployed into each vial. Flies 190 
 9 
were left in the these ‘exposure vials’ for three days to allow them to ingest the 191 
viral solution during feeding and grooming, and then tipped into vials containing 192 
clean, blue-dyed Lewis medium (see below).  193 
 194 
Survival following infection 195 
Both systemically and orally infected flies were housed individually following 196 
infection in vials containing Lewis medium. In the systemic infection experiment, 197 
flies were monitored daily for mortality for 38 days post-infection and were 198 
transferred to fresh food vials once a week. In the oral infection experiment, flies 199 
were transferred to fresh food vials every 3-4 days, and mortality was recorded 200 
at this point for the first 32 days post infection and then daily until 40 DPI (oral 201 
infection).  202 
 203 
Fecal excretion following oral DCV exposure 204 
Following the exposure period, flies were tipped into vials containing blue-dyed 205 
Lewis medium. Blue medium was prepared by adding 0.5g/L FIORI COLORI 206 
brilliant blue FCF E133 granules to standard Lewis medium. Flies remained on 207 
blue Lewis food for the remainder of the experiment and were tipped to new 208 
blue Lewis vials every three to four days. When flies were tipped to new vials, 209 
the old vials were kept for fecal spot counts (measured immediately) and 210 
fecundity measures (see below). Fecal spots were recorded by photographing 211 
vials with a Leica S8APO microscope. A slip of white printer paper (2.5cm x 212 
8.5cm) was inserted into each vial to ensure only spots on one side of the vial 213 
were being photographed. These images were then analyzed with ICY image 214 
software (Version 1.6.1.1 ICY - Bio Imaging Analysis) and fecal spots were 215 
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counted using ‘spot detection’ analysis on a 2cm x 4cm region of interest. Each 216 
image was checked individually for miscounts, and miscounted spots were 217 
removed. Fecal excretion was recorded for 30 days following infection.  218 
 219 
Fecundity 220 
All fecundity estimates are based upon mating that occurred before infection 221 
during the first 3-4 days after eclosion. The fecundity of individual flies was 222 
measured by counting viable offspring emerging in the vials they were reared in, 223 
which happened weekly until day 30 post infection in the systemically infected 224 
flies, and every 3-4 days in the orally infected flies, for 28 days following 225 
exposure to DCV. Short-term fecundity estimates have been shown to be well 226 
correlated with lifetime reproduction in D. melanogaster (Nguyen & Moehring, 227 
2015). Vials that individuals were tipped from (and following the recording of 228 
fecal shedding in the oral infection experiment), were placed in the incubators at 229 
24.5°C ± 0.5 with a 12h:12h light:dark cycle to allow any offspring to develop. 230 
After 14 days, the total number of living emerged adult offspring within each vial 231 
was recorded as a measure of female fecundity.  232 
 233 
Activity 234 
Locomotor activity was measured using the Drosophila Activity Monitor (DAM2, 235 
Trikinetics) as described previously (Pfeiffenberger et al., 2010; Vale & Jardine, 236 
2015). In the DAM, individual fly activity is recorded when individually housed 237 
flies break an infrared beam passing through a transparent plastic tube placed 238 
symmetrically inside a DAM unit. In systemically infected flies, as we used 239 
females to measure fecundity (see above), activity was measured on 10 replicate 240 
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male flies for each DCV dose (40 flies in total), starting the day following septic 241 
injury, and measured for 2 weeks following infection. In the oral infection 242 
experiment, activity was recorded for 24 hours, fourteen days after the initial 243 
oral exposure. These differences in the timing of activity measurements arise 244 
from the faster and more severe effects of systemic infections on locomotor 245 
behavior, while we have found that effects on activity following oral infection 246 
take longer to manifest, and become apparent 10-15 days after  DCV 247 
ingestion(Vale & Jardine, 2015). Four replicate flies for each DGRP (10 lines) / 248 
sex (M/F) / infection (DCV/Control) combination were tested (160 flies in total).  249 
In both experiments, flies were placed individually in a single DAM tube 250 
containing a small agar plug on one end, and allocated a slot in one of five DAM 251 
unit (each unit can house a maximum of 32 tubes). At least one slot in each DAM 252 
unit was filled with an empty tube and at least two slots were left empty as 253 
negative controls. All DAM units were placed in the incubator (25 °C 12:12 254 
light:dark cycle) and continuous activity data was collected every minute for 24 255 
hours. Raw activity data was processed using the DAM System File Scan Software 256 
(www.trikinetics.com) and the resulting data was manipulated using R v. 3.1.3 257 
(The R Foundation for Statistical Computing, Vienna, Austria). Flies that died 258 
during the DAM assay (6/40 flies in the systemic infection experiment; 25/160 259 
in the oral infection experiment) were removed from the analysis because they 260 
would wrongly bias the estimate of activity.  261 
 262 
Data analysis 263 
All analyses were carried out in JMP 12 (SAS). Survival data was analyzed on the 264 
‘day of death’ using a Cox Proportional Hazards models in with ‘fly sex’ and ‘DCV 265 
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exposure’ and their interaction as fixed effects (systemic infection experiment) 266 
or ‘fly sex’, fly ‘line’ and ‘DCV dose’ and their interactions as fixed effects (oral 267 
infection experiment). In the systemic infection, DCV titers were Log10-268 
transformed and analyzed in a linear model with ‘DCV Dose’ and ‘Sex’ and their 269 
interaction as fixed effects. Fecundity following systemic infection was calculated 270 
on the cumulative number of emerged offspring in a model containing ‘DCV dose’ 271 
as a fixed effect. In the oral exposure experiment, the cumulative number of 272 
offspring was analyzed in a model including ‘Fly line’ and ‘DCV exposure’ and 273 
their interaction as fixed effects. Total excretion per fly was analyzed using a 274 
linear model with ‘Fly line’, ‘DCV exposure’, and ‘sex’ as categorical fixed effects, 275 
’Time’ as a continuous covariate, and all pair-wise interactions. Activity was 276 
analyzed as the total number of DAM beam breaks recorded per day. Activity 277 
following systemic infection was analyzed in a linear model with ‘DCV dose’ and 278 
‘Time’ as fixed effects. Activity following oral infection was measured for 24h and 279 
analyzed in a linear model with ‘Fly line’, ‘Sex’ and ‘DCV exposure’ as fixed 280 
effects. In all analyses, individual replicate was included as a random factor, and 281 
in all cases accounted for only 2-5% of the total variance. 282 
  283 
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RESULTS  284 
Experiment 1: Sub-lethal systemic infection 285 
In a first experiment, we tested how systemic infection with very low 286 
concentrations of DCV (102, 103 and 105 DCV IU/ ml ) affected fly health. We have 287 
previously observed that DCV is able to establish and grow when inoculated into 288 
flies at these low doses (Figure S2). The survival of both female and male flies 289 
exposed to doses of 102 and 103 DCV IU/ ml did not differ from control flies that 290 
had been pricked with sterile buffer solution (Figure 1a). In females, 100% flies 291 
exposed to these doses survived infection during the 38-day survival assay, 292 
while roughly 20% of males died during this period (Figure 1a). However, this 293 
difference in survival between sexes (‘sex’ effect, Table 1), was also observed in 294 
control flies and therefore is likely to reflect sex-specific responses to injury 295 
during intra-thoracic pricking than to infection. Flies infected with a slightly 296 
higher concentration of 105 DCV IU/ ml died significantly faster than control 297 
flies. This virus concentration-specific pattern of mortality was generally 298 
consistent with the observed DCV titers measured 5 days following infection, 299 
(Table 2, ‘dose’ effect) which were generally higher in male flies across all DCV 300 
concentrations (Table 2, ‘sex’ effect, Figure 1b). Our experiment therefore 301 
spanned the range of sub-lethal viral doses, with 105 DCV IU/ ml being the 302 
lowest virus concentration with lethality in the experiment (Figure 1a).  303 
 304 
Fecundity following systemic DCV infection  305 
We used mated females, which allowed us to quantify fly reproductive health 306 
during systemic infection by following the number of adult offspring produced 307 
by individual females for 30 days following infection. The total fecundity 308 
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measured during this period varied according to the dose females had received 309 
(F3,66 = 10.32, p<0.0001) and we observed that the total reproduction of infected 310 
flies was higher than control flies, and increased in a dose-specific manner 311 
(Figure 1c).  312 
 313 
Activity following systemic DCV infection  314 
The locomotor activity of individual male flies infected systemically with all sub-315 
lethal concentrations of DCV was measured during 18 days after infection in a 316 
Trikinetics® Drosophila Activity Monitor (DAM). All flies included in the analysis 317 
remained alive for the whole period, so changes in activity were not confounded 318 
with potential death of individual flies. We found that flies in all treatments, 319 
including uninfected controls, showed a reduction in activity over the course of 320 
the activity assay (Figure 1d, Table time effect). This general effect is not 321 
especially surprising given the constrained environment experienced by flies in 322 
the DAM tubes, and that the only source of nutrition and hydration is small agar 323 
plug. However, our analysis showed that the temporal reduction in activity 324 
depended on the dose that flies had received (‘time x dose’ interaction, Table 1). 325 
In the early stages of infection flies receiving the higher of the 4 doses (103 and 326 
105 DCV copies) showed a reduction in activity relative to control flies and those 327 
receiving the lowest dose. Over time, a reduction in locomotor activity was most 328 
apparent in flies infected with the highest dose of 105 DCV copies (Figure 1d).  329 
 330 
Experiment 2: Sub-lethal gut infection 331 
In a separate experiment, we tested how exposure to a single sub-lethal dose of 332 
DCV through the oral route of infection impacted upon fly health.  We conducted 333 
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the experiment on ten fly lines from the DGRP panel (Mackay et al., 2012) and we 334 
included both male and female flies to test for the effects of host genetic 335 
background and sex in response to sub-lethal oral infection. While DGRP lines 336 
differ in their lifespan in the absence of infection (Durham et al., 2014), we did 337 
not detect any difference between DGRP lines or between sexes in their survival 338 
during oral DCV infection compared to control flies (Table S1) which, as 339 
expected, was generally non-lethal across all lines.  340 
 341 
Fecundity following oral exposure to DCV  342 
Despite not observing any effects on fly survival during infection, we detected 343 
significant variation in reproductive health following exposure to DCV. The total 344 
fecundity of females during the 28 days following oral exposure to DCV (or a 345 
control inoculum) varied significantly between DGRP lines (Figure 2; Table 2), 346 
reflecting well-known genetic differences in the lifetime reproductive output of 347 
these lines (Durham et al., 2014). In addition, we found line-specific fecundity 348 
responses to DCV infection (‘infection status x line’, Table 2, see also Table S2 for 349 
pairwise contrasts). In some lines (158, 491, 317) low-level oral infection 350 
resulted in a decrease in fecundity; in other lines (821, 358) there was no 351 
detectable effect of DCV exposure; while in 2 lines we detected significant 352 
increases in fecundity in DCV infected flies compared to uninfected control flies 353 
of the same genetic background (Figure 2; see Table S2 for least-square pairwise 354 
contrasts).  355 
 356 
Locomotor activity following oral exposure to DCV  357 
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Overall, DGRP lines differed in their activity in a sex specific way (‘Fly line x Sex’ 358 
effect Table 2), but these differences were not altered by infection. While we 359 
detected a reduction in locomotor activity following systemic infection (Figure 360 
1d), we did not detect any effect of oral DCV exposure on the overall activity of 361 
flies (Table 2, Figure 3).  362 
 363 
Fecal excretion following oral exposure to DCV  364 
We quantified fecal excretion for 30 days following DCV exposure as a proxy for 365 
gut health, by counting fecal spots excreted into vials after ingestion of blue-dyed 366 
food. Overall we found that males showed higher levels of fecal excretion 367 
compared to females (Table 2, ‘sex’ effect; Figure 4) and that DCV infection was 368 
associated with a general reduction in fecal excretion throughout the 30-day 369 
observation period (‘Infection status’ effect, Figure 4). However, we found that 370 
males and females differed in the overall severity of this reduction (‘sex x 371 
infection status’ effect), with males showing a greater reduction in defecation 372 
overall (Figure 4). Furthermore, we found significant variation among the DGRP 373 
lines in the magnitude of the effect of DCV on fecal excretion (‘fly line x infection 374 
status’ effect).   375 
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DISCUSSION 376 
 377 
We find that sub-lethal infections with DCV can cause measurable morbidity that 378 
is relevant for the fitness costs experienced by D. melanogaster during DCV 379 
infection. In two independent experiments using sub-lethal concentrations of 380 
either systemic or oral DCV infections, we observed effects on fly reproductive 381 
output, digestive health, and locomotor activity.  382 
 383 
Systemically infected flies increase reproductive output  384 
We found that the fly line used in the systemic infection experiment showed an 385 
increase in reproductive output when infected with sub-lethal doses of DCV. 386 
There are numerous examples from both invertebrates and vertebrates of 387 
fecundity increases following infection (Bonneaud et al., 2004; Vale & Little, 388 
2012; Leventhal et al., 2014; Vézilier et al., 2015). In addition, earlier work 389 
reported that DCV infection could increase ovariole number and decrease 390 
development time in D. melanogaster (Thomas-Orillard, 1984; Gomariz-Zilber & 391 
Thomas-Orillard, 1993). However, a subsequent re-analysis of these data showed 392 
very weak support for the beneficial effects of DCV infection (Longdon, 2015). It 393 
is notable however that neither of the earlier studies measured the number of 394 
viable offspring of infected flies compared to healthy ones. The fecundity data we 395 
report therefore suggests that DCV may indeed result in increased reproductive 396 
output.  397 
 398 
A dose-dependent increase in fecundity could suggest a direct effect of DCV 399 
infecting fly ovaries, but it is unclear why such a strategy would be adaptive for 400 
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the virus. An alternative hypothesis may instead involve more complex 401 
interactions between the allocation of resources during DCV infection, and how 402 
they relate to fly nutritional stress and reproductive investment. For example, D. 403 
melanogaster females selected under conditions of nutritional stress were found 404 
to produce a greater number of ovarioles, while the offspring of starved mothers 405 
also exhibited greater investment in reproduction (Wayne et al., 2006). Similar 406 
to the studies described above (Thomas-Orillard, 1984; Gomariz-Zilber & 407 
Thomas-Orillard, 1993), this work also focused on ovariole number and egg 408 
production, and did not quantify female lifetime fecundity. Given that DCV 409 
infection is known to lead to intestinal obstruction, one possibility for the 410 
increase in the number of adult offspring we observed in infected flies is that 411 
DCV-induced nutritional stress leads to a greater production of ovarioles, and 412 
consequently, an increased number of offspring.  Given we only tested a single fly 413 
line however, it important to note that this response may not be universal. As we 414 
discuss below fecundity responses to infection have generally been found to 415 
differ between host genotypes  (Vale & Little, 2012; Parker et al., 2014) 416 
 417 
Fecundity costs and benefits of DCV infection are genotype-specific 418 
Similar to systemically infected flies (Figure 1c), we also find evidence for 419 
fecundity benefits in orally exposed flies, but these benefits were only revealed 420 
in two out of the ten genetic backgrounds we tested. Indeed, in three of the 421 
tested lines, DCV infection resulted in lower reproductive output. Taking 422 
fecundity as a proxy for evolutionary fitness, the existence of genotype specific 423 
fitness costs and benefits means that DCV could be a potentially powerful driver 424 
of D. melanogaster evolutionary dynamics. Previous analyses of Drosophila spp. 425 
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population genetic data have shown that the fastest evolving D. melanogaster 426 
genes are those involved in RNAi-based antiviral defense (Obbard et al., 2006, 427 
2009; Early et al., 2016), but the DCV-induced fitness costs that drive this rapid 428 
evolution in wild-infected flies (where infections are persistent and often non-429 
lethal), has remained obscure. These data suggest that genotype-specific 430 
fecundity costs and benefits of DCV infection could potentially mediate the arms-431 
race between flies and viruses. 432 
 433 
Systemically infected flies show a dose-dependent decline in activity over time 434 
Reduced activity, or lethargy, following infection is a common response to 435 
infection across a range of taxa (Hart, 1988; Adelman & Martin, 2009; Sullivan et 436 
al., 2016). The most obvious explanation for reduced activity is simply that 437 
infected individuals are sick, and lethargy reflects the underlying pathology of 438 
infection (Moore, 2013). A popular alternative explanation is that infection-439 
induced lethargy evolved as an adaptive host strategy that conserves energy, 440 
which may then be allocated to other physiological tasks such as mounting an 441 
immune response (Hart, 1988; Adelman & Martin, 2009).  442 
 443 
Support for the adaptive nature of these ‘sickness behaviours’ has come mainly 444 
from vertebrate species challenged with deactivated pathogens or their derived 445 
components, which are sufficient to stimulate an immune response without 446 
causing pathology (Adelman & Martin, 2009; Lopes et al., 2016). In addition to 447 
vertebrates, sickness behaviors including lethargy and anorexia have also been 448 
described in insect hosts (Ayres & Schneider, 2009; Kazlauskas et al., 2016; 449 
Sullivan et al., 2016). However, in the current experiment it is not possible to 450 
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disentangle the effect of an adaptive sickness behavior from the direct effect of 451 
pathology caused by replicating DCV. Regardless of the underlying cause of 452 
reduced activity, it is likely to come at an additional cost of lower involvement in 453 
fitness-enhancing activities such as foraging, competing for resources with 454 
conspecifics, or courtship and mating (Adelman & Martin, 2009; Adamo et al., 455 
2015; Vale & Jardine, 2016). Further, reduced activity following infection can 456 
also reduce the potential for disease spread (Lopes et al., 2016). In the context of 457 
understanding sub-lethal DCV infection in an ecological setting, reduced activity 458 
may therefore be a potentially important source of DCV-induced fitness costs 459 
and benefits. 460 
 461 
We did not find an effect of oral DCV exposure on fly activity. Previous work has 462 
shown that Drosophila, especially females, show a reduction in activity following 463 
oral infection with DCV (Vale & Jardine, 2015). However, the viral concentration 464 
that flies were exposed to in that experiment was at least 1000x higher, so it is 465 
likely that in the current experiment flies did not ingest virus in quantities large 466 
enough to affect locomotor activity.  467 
 468 
The severity of DCV-induced digestive dysfunction is sex-specific 469 
Previous work has shown that DCV infection results in digestive dysfunction, 470 
leading to increased body mass due to the inability to excrete digested food 471 
(Arnold et al., 2013; Chtarbanova et al., 2014). We found that this measure of gut 472 
health varied between genotypes and also between sexes. Extensive genetic 473 
variation for gut immune-competence has previously been reported in the DGRP 474 
panel (Bou Sleiman et al., 2015), which could underlie some of the variation we 475 
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observe in DCV-associated digestive dysfunction in some lines.   Although that 476 
study focused on enteric infection with entomopathogenic bacteria, the 477 
mechanisms that mediate variation in gut health during infection include general 478 
processes of gut damage and repair, such as the production of reactive oxygen 479 
species (ROS) and the production of intestinal stem cells during epithelial repair 480 
(Buchon et al., 2013). It is plausible that these mechanisms also mediate disease 481 
severity during enteric virus infection, but we are unaware of any systematic 482 
study of genetic variation in gut immune-competence during viral infection.  483 
 484 
The mechanistic basis of the observed sex differences in fecal excretion is less 485 
clear. The Malpighian tubules are the main organ involved in osmoregulation and 486 
excretion of waste matter in insects (Dow & Davies, 2001). D. melanogaster male 487 
and female Malpighian tubules have been shown to differ at the transcriptional 488 
level with over 18% of genes (2308 genes) showing sex-specific expression 489 
(Huylmans & Parsch, 2014). We measured fecal excretion by quantifying fecal 490 
spots on the sides of the vials. Given that females are known to also spend more 491 
time feeding  (Wong et al., 2009), it is possible that females also defecate more 492 
on the surface of the food compared to males, and therefore spend less time on 493 
the sides of the vials. Only a few studies have investigated sex differences in fecal 494 
excretion in D. melanogaster, finding inconsistent patterns of excretion between 495 
sexes (Zeng et al., 2011; Urquhart-Cronish & Sokolowski, 2014). The link 496 
between fecal excretion and fitness is not as clear as with fecundity or locomotor 497 
activity, but it is relevant in the context of disease transmission of fecal-orally 498 
transmitted pathogens such as DCV. The study of temporal trends in fecal 499 
excretion and how they vary with host sex and genetic background may 500 
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therefore be used as a useful model to understand the sources of heterogeneity 501 
in pathogen shedding (Vale et al., 2013).   502 
 503 
Concluding remarks 504 
Altogether, these measures of sub-lethal morbidity give insight into the potential 505 
fitness costs of low-level, persistent DCV infection in Drosophila. More generally, 506 
the combination of both positive and negative effects on fly fitness effects 507 
according to the specific host genetic background presents a non-trivial 508 
evolutionary scenario for host immune defense (Gandon & Vale, 2014). For 509 
instance, frequent encounters between beneficial symbionts and detrimental 510 
pathogens are hypothesized to have played a role in the evolution of aphid 511 
immune systems, which lack several components of the IMD immune pathway 512 
critical for the recognition and elimination of Gram-negative bacteria (Gerardo et 513 
al., 2010). The combination of fitness costs and benefits of infection, such as 514 
those incurred during DCV infection, may therefore have driven the evolution of 515 
immune defense across a wide range of host taxa, from insects to mammals 516 
(Elsik, 2010; Gerardo et al., 2010; Lee & Mazmanian, 2010; Gandon & Vale, 517 
2014).  518 
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 718 
Figure legends 719 
 720 
Figure 1. Sub-lethal systemic infection. 1a. Kaplan-Meier curves showing the 721 
survival of 20 replicate flies exposed systemically to sub-lethal concentrations of 722 
DCV. 1b. DCV titers measured in male and female flies relative to an internal 723 
control gene (rp49), following 3 days of systemic infection with sub-lethal 724 
concentrations of DCV. For each DCV concentration, data are the average of 725 
duplicate qPCR reactions for 5 individual flies. 1c. The total number of emerged 726 
adult offspring recorded for 30 days following systemic infection based on 727 
mating that occurred before infection during the first 3-4 days after eclosion. 728 
Data are the means ± SE of 18-19 replicate female flies. 1d. Daily locomotor 729 
activity of male flies following systemic infection with DCV. Data are 3 day 730 
averages of 7-10 replicate flies for each inoculation concentration. UC are 731 
uninfected controls. 732 
 30 
 733 
 734 
Figure 2.  Fecundity following oral DCV exposure. 2a. The cumulative number of 735 
adult offspring from healthy (light bars) or DCV-exposed (dark bars) single 736 
female flies over the course of the 28-day experiment.  2b. Shows the fecundity 737 
difference between healthy and infected flies for the same 10 DRGP lines. In both 738 
plots, DGRP lines are ordered from the greatest decrease to the highest fecundity 739 
increase. Significant pairwise contrasts (reported in Table S2) are indicated by 740 
asterisks. Data are the mean ± SE of eight individual replicate females. 741 
 31 
 742 
 743 
Figure 3. Locomotor activity following oral DCV exposure. Data show mean ± SE 744 
activity of four replicate flies per sex and DGRP line, measured for 24 hours 14 745 
days following exposure to DCV (red) or uninfected controls (grey). 746 
 747 
  748 
 32 
749 
Figure 4. Fecal excretion following oral DCV exposure. 4a. The general effect of 750 
DCV exposure (red) or a control inoculum (grey) on the number of fecal spots 751 
shed over time. Data are plotted separately for males and females. Each time 752 
point is the mean ± SE of 8 replicate individual flies averaged across all 10 DGRP 753 
lines. 4b. Shows the difference between control and infected flies for each DRGP 754 
line. Data are the mean ± SE of eight individual replicate flies for each sex and 755 
line combination.  756 
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Tables 757 
Table 1 - Systemic infection     
 Survival DF 2 p-value 
DCV concentration 4 45.24 0.0001 
Sex 1 8.37 0.0038 
DCV concentration  Sex 2 8.26 0.0161 
    Viral titer DF F Ratio p-value 
DCV concentration 3 3.14 0.0399 
Sex 1 7.34 0.0111 
DCV concentration   Sex 3 1.35 0.2776 
    Activity per day 
   Time (DPI) 1 290.68 0.0001 
DCV concentration 3 5.17 0.0016 
Time (DPI)  DCV concentration 3 5.51 0.001 
  
     758 
 34 
Table 2 - Oral infection       
Fecundity DF F Ratio 
p-
value 
DGRP Line 9 16.17 <.0001 
DCV exposure 1 0.99 0.3186 
DGRP Line  DCV exposure 9 2.59 0.0076 
    
Activity per day 
   DGRP Line 9 2.91 0.0037 
Sex 1 0.02 0.8947 
DCV exposure 1 1.45 0.2315 
DGRP Line  Sex 9 2.18 0.0277 
DGRP Line  DCV exposure 9 0.67 0.7352 
Sex  DCV exposure 1 0.12 0.7244 
    
Fecal excretion 
   DGRP Line 9 32.17 0.0001 
Sex 1 212.66 0.0001 
Time (DPI) 1 29.95 0.0001 
DCV exposure 1 72.83 0.0001 
DGRP Line  DCV exposure 9 4.46 0.0001 
Sex  DCV exposure 1 13.45 0.0003 
Time (DPI)  DCV exposure 1 0.23 0.6295 
DGRP Line  Sex 9 31.22 0.0001 
DGRP Line  Time (DPI) 9 1.28 0.2405 
Sex  Time (DPI) 1 0.06 0.806 
 759 
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 764 
 765 
Supplementary File for 766 
 767 
Costs and benefits of sub-lethal Drosophila C Virus infection 768 
 769 
 770 
 771 
This file contains: 772 
 773 
- Table S1. Cox proportional hazards analysis of survival following oral 774 
exposure to DCV.  775 
 776 
- Table S2. Least Square Means Student’s t pairwise contrasts between 777 
exposed and control fecundity following oral DCV exposure. 778 
 779 
- Figure S1. DCV increases in titer following oral exposure to approximately 780 
105 DCV copies. 781 
 782 
- Figure S2. DCV increases in titer following systemic challenge with 102, 783 
103 and 105 DCV IU/ ml. 784 
 785 
 786 
 787 
 788 
 789 
 790 
 791 
 792 
 793 
  794 
 36 
Table S1. Output of Cox proportional hazard model testing variation in 795 
survival following oral infection. 796 
 797 
Survival during oral infection DF 2 p-value 
DGRP Line 9 3.87084122 0.9197 
Sex 1 3.82E-07 0.9995 
DGRP Line*Sex 9 2.85864198 0.9696 
Infection status 1 4.73E-08 0.9998 
DGRP Line* Infection status 9 0.74383375 0.9998 
Sex* Infection status 1 1.07E-06 0.9992 
DGRP Line*Sex* Infection status 9 0.25051421 1 
    
 798 
 799 
 800 
 801 
Table S2. Least Square Means Student’s t pairwise contrasts between 802 
exposed and control fecundity following oral DCV exposure 803 
DGRP line NumDF F Ratio p-value 
83 1 5.0178 0.036 
91 1 0.2916 0.590 
158 1 7.4368 0.007 
237 1 5.6287 0.019 
287 1 1.0515 0.306 
317 1 4.6993 0.042 
358 1 0.0525 0.819 
491 1 4.7059 0.031 
732 1 0.3253 0.569 
821 1 0.0813 0.776 
 804 
 805 
 806 
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 807 
 808 
 809 
Figure S1. DCV increases in titer following oral exposure to with approximately 810 
105 DCV copies (F1,27 = 57.97, p< 0.001). This experiment was carried out in D. 811 
melanogaster OreR. Data show the Log2 DCV expression relative to an internal 812 
Drosophila control gene (rp49), measured in six individual female flies at each 813 
time point following exposure. Oral exposure to DCV was carried out as 814 
described in the main text.  815 
 816 
 817 
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 819 
Figure S2. These data show DCV expression relative to the internal control gene 820 
RpL32 measured at roughly 8-hour intervals. Male (M) of female (F) D. 821 
melanogaster (Oregon R, Wolbachia-negative) were challenged with 2, 3 or 5 822 
Log10 DCV IU/ml. Data show means ± SE of duplicate qPCRs on 3 replicate 823 
groups of 5 flies per sex/DCV concentration.  824 
 825 
 826 
